Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, September 26, 2023
[ Tue, Sep 26th 2023
] - WOPRAI
[ Tue, Sep 26th 2023
] - WOPRAI
[ Tue, Sep 26th 2023
] - WOPRAI
Mon, September 25, 2023
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
Peter Welford Upgraded (AZN) to Strong Buy and Increased Target to $80 on, Sep 25th, 2023
Peter Welford of Jefferies, Upgraded "AstraZeneca PLC" (AZN) to Strong Buy and Increased Target from $67 to $80 on, Sep 25th, 2023.
Peter has made no other calls on AZN in the last 4 months.
There are 2 other peers that have a rating on AZN. Out of the 2 peers that are also analyzing AZN, 0 agree with Peter's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Peter
- Etzer Darout of "BMO Capital" Maintained at Buy with Increased Target to $83 on, Tuesday, August 1st, 2023
- Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Decreased Target to $80 on, Friday, May 26th, 2023
